Percutaneous laser revascularisation for refractory angina pectoris

control arms of the studies (2% [5/287]) (significance and follow-up not stated). 2.4.5 The Specialist Advisers listed adverse events reported in the literature as myocardial infarction, arrhythmias and puncture site complications. They considered theoretical adverse events to include death, perforation of the cardiac muscle, damage to coronary arteries or other important structures, stroke and pericardial effusion. 3 Further information 3.1 NICE has published interventional procedures guidance on transmyocardial laser revascularisation for refractory angina pectoris, technology appraisal guidance on myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction, and a guideline on the management of stable angina. Information for patients NICE has produced information on this procedure for patients and carers ('Understanding NICE guidance'). It explains the nature of the procedure and the guidance issued by NICE, and has been written with patient consent in mind. Update information Minor changes since publication
